Trade Summary

1 week ago, Lyssikatos Joseph P, serving as CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 5,000 shares at $16.84 per share, for a total transaction value of $84,206.00. Following this transaction, Lyssikatos Joseph P now holds 897,688 shares of ELVN.

This sale represents a 1.00% decrease in Lyssikatos Joseph P's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, December 19, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 4 days after the trade was made.

Enliven Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.